Skip to main content

Nasdaq IPOs

Cancer biotech IN8bio postpones $75 million IPO

5 years 11 months ago
IN8bio, a Phase 1 oncology biotech developing allogeneic gamma-delta T cell therapies, postponed its IPO on Friday. It had filed to raise $75 million by offering 4.7 million shares at a price range of $15 to $17. The New York, NY-based company was founded in 2016 and had planned
Renaissance Capital

Research instrument provider Seer files for a $150 million IPO

5 years 11 months ago
Seer, which provides a proteograph product suite for biomedical research, filed on Thursday with the SEC to raise up to $150 million in an initial public offering. The company aims to commercialize proteome research products starting with its initial product, the Proteograph Pro
Renaissance Capital

Lab services provider Sotera Health sets terms for $1 billion IPO

5 years 11 months ago
Sotera Health, which provides lab services to the medical device and pharma industries, announced terms for its IPO on Thursday. The Broadview Heights, OH-based company plans to raise $1.0 billion by offering 46.6 million shares at a price range of $20 to $23. At the midpoint of
Renaissance Capital

Cybersecurity solutions provider Telos sets terms for $210 million IPO

5 years 11 months ago
Telos, which provides software-based security products and services, announced terms for its IPO on Tuesday. The Ashburn, VA-based company plans to raise $210 million by offering 12.4 million shares at a price range of $16 to $18. At the midpoint of the proposed range, Telos wou
Renaissance Capital

Soil remediator Vivakor files for a $15 million IPO

5 years 11 months ago
Vivakor, which provides soil remediation services focused on hydrocarbon extraction, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. The company is currently listed on the OTC under the symbol "VIVK." Vivakor operates, acquires, and d
Renaissance Capital
Checked
26 minutes 18 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed